LIDBREE 42 mg/ml, gel intrauterine syringe, 10 ml
Active ingredients: Lidocaine
Commercialized according to BDPMDispensing in France: Prescription only
Gelsyringe, 10 mlendocervicale;intra-utérine
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LIDBREE 42 mg/mL, gel intra-utérin
- Pharmaceutical form
- gel
- Route of administration
- endocervicale;intra-utérine
- Presentation description
- 1 seringue préremplie copolymère de cyclooléfines de 10 mL avec applicateur stérile polypropylène embout Luer-Lock
- Marketing authorisation holder
- GEDEON RICHTER ( HONGRIE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61348523CIP73021212CIP133400930212127Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LIDOCAÏNEgel | 42 mg · un 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.